RecallDepth
Class II Ongoing

Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ 07054, NDC 67877-262-18

This recall is currently active, issued July 23, 2025. It was issued by Ascend Laboratories, Llc.

Company
Ascend Laboratories, Llc
Recall Initiated
July 9, 2025
Posted
July 23, 2025
Recall Number
D-0534-2025
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Bedminster, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.

Distribution

US Nationwide.

Lot / Code Info

Lot 22143653, 22143675, Exp Date: July 2025; Lot 22144528, Exp Date: September 2025; Lot 22144977, Exp Date: November 2025; Lot 23140257, Exp Date: December 2025; Lot 23140999, Exp Date: Feb. 2026; Lot 23141900, 23142118, 23142120, 23142123, Exp Date: May 2026; Lot 23144563, 23144565, Exp Date: November 2026; Lot 24142623, Exp Date: May 2027; Lot 24142624, 24142626, 24143469, Exp Date: Jun. 2027.

More recalls by Ascend Laboratories, Llc

View all recalls by this company →

Other recent Class II Drug recalls